Acute liver failure is a high-mortality emergency requiring rapid recognition, transplantation evaluation, and targeted management of cerebral edema,...
At the Bedside
- Definition
- Acute liver injury with encephalopathy and INR ≥ 1.5 in a patient without preexisting cirrhosis, typically within weeks of symptom onset.
- Key causes
- Acetaminophen, viral hepatitis, ischemic hepatitis, autoimmune hepatitis, Wilson disease, toxins, pregnancy-related causes, vascular causes, and indeterminate.
- ED priorities
- ABCs, mental status, bedside glucose.
- Treat hypoglycemia immediately.
- Assess for encephalopathy grade, bleeding, infection, shock, and cerebral edema.
- Workup
- CMP, AST/ALT, bilirubin, INR/PTT, fibrinogen, CBC, ammonia, lactate, VBG/ABG, creatinine, glucose.
- Acetaminophen level in all acute liver failure presentations, even if history is unclear.
- Hepatitis serologies, autoimmune markers, pregnancy test when indicated, ceruloplasmin/hemolysis evaluation if Wilson disease suspected.
- RUQ ultrasound with Doppler if vascular/biliary pathology suspected.
- Blood cultures if infection possible.
- Management
- N-acetylcysteine (NAC) for suspected or confirmed acetaminophen toxicity, and often empirically in undifferentiated acute liver failure because of benefit and safety.
- ICU care; early hepatology and transplant center consultation.
- Manage encephalopathy with airway protection if needed; lactulose is often used though acute liver failure management is broader than cirrhosis.
- Avoid unnecessary sedatives; maintain euvolemia and normoglycemia.
- Monitor for cerebral edema: worsening mental status, hypertension/bradycardia, pupillary changes.
- Disposition
- Many patients require transfer to a liver transplant center if not already at one.
- Coagulopathy alone is not the endpoint; prognosis depends on mental status, INR, creatinine, lactate, and etiology.
Classic Presentation
A 19-year-old woman presents 24 hours after a large acetaminophen ingestion with nausea, right upper quadrant pain, and confusion. Her AST and ALT are in the thousands, INR is 3.2, and glucose is low. She is started on IV NAC, glucose is corrected, and hepatology is contacted urgently for transplant evaluation and ICU admission.
Study Directive
- Memorize the definition of acute liver failure and the major causes.
- Practice a 30-second transplant referral summary: etiology, INR, glucose, creatinine, lactate, mental status, and timeline.
- Write out the IV NAC regimen from memory and know when it may need extension.
- Review indicators of poor prognosis and when to escalate to a transplant center.
- Do one case on Wilson disease vs acetaminophen toxicity in acute liver failure.
---
Mechanism Pearl of the Day: Several of today’s toxidromes hinge on whether a toxin pushes the body toward
acidemia or sympathetic overdrive: salicylates and toxic alcohols create dangerous acid-base shifts that increase tissue penetration and organ injury, while stimulants and sedatives threaten by overwhelming physiologic reserve through autonomic excess or CNS/respiratory depression.
Key Medications
- N-acetylcysteine (IV):
- Common 21-hour regimen: 150 mg/kg over 1 hr, then 50 mg/kg over 4 hr, then 100 mg/kg over 16 hr.
- Many centers extend or repeat NAC until liver injury improves; verify institutional protocol.
- N-acetylcysteine (PO): 140 mg/kg load, then 70 mg/kg every 4 hr x17 doses if used.
- Dextrose: 25 g IV for hypoglycemia, repeat as needed.
- Lactulose: 20–30 g PO/NG, titrated to 2–3 soft stools/day; use with caution and based on encephalopathy management plan.
- Vitamin K: 5–10 mg IV/PO if deficiency possible; does not fix true synthetic failure but may help if deficient.
- Note: NAC duration often depends on transaminases, INR, creatinine, mental status, and acetaminophen detectability.
High-Yield Pearls
- Acute liver failure is defined by encephalopathy plus INR elevation, not by transaminase level alone.
- Acetaminophen level should be checked in all cases—history is often unreliable.
- Hypoglycemia and cerebral edema are immediate threats and can kill before transplant becomes possible.
Board Question
Which of the following is the most appropriate empiric therapy for an undifferentiated patient with acute liver failure and encephalopathy?
- AN-acetylcysteine
- BFlumazenil
- CActivated charcoal only
- DLactated Ringer’s infusion as definitive therapy
Reveal answer
Correct: A
N-acetylcysteine is recommended for suspected acetaminophen toxicity and is commonly given empirically in undifferentiated acute liver failure because of safety and potential benefit. Flumazenil is not indicated, charcoal is not definitive once liver failure is present, and fluids alone do not treat the underlying hepatic injury.